Huntington’s Disease Research-2017 Feb

Huntington’s Disease Research-2017 Feb

in 2017, Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target BACKGROUND: Focus on the CB2 receptor as a promising pharmacological target in a number of neurodegenerative diseases. You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288380/

Huntington’s Disease-Research-2009 Aug

In 2009, Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington’s disease BACKGROUND: Examined this hypothesis in a rat model of Huntington’s disease (HD) generated by intrastriatal injection of the mitochondrial complex II inhibitor malonate. You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706932/

Huntington’s Disease Study-2017 Sep

In 2017, New Study Says Eating Raw Weed Protects Against Brain Diseases BACKGROUND: THCA is actually the non-psychoactive cannabinoid that later converts to THC when decarbed via smoking, vaporization or when cooked, and as it turns out, it’s pretty powerful in its own right. You can read the full article here => https://herb.co/marijuana/news/raw-weed-benefits

Huntington Disease Research-2016 Jun

In 2016, Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids BACKGROUND: We hypothesized that proteotoxicity in nerve cells themselves may initiate an inflammatory response that can lead directly to their death and contribute to overall inflammation in the CNS. The following experiments identify the molecular basis of this inflammatory response using a human CNS nerve cell .. Read More